This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.
Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric/stomach cancer, and liver cancer)
Signed informed consent that will be put on file
No informed consent obtained
Specimen unacceptable/degraded/etc.
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
University of California, Davis
Lead sponsor
National Cancer Institute (NCI)
Collaborator